The Effect of Red Light on Cognition and Motor Symptoms in Alzheimer’s and Parkinson’s Disease The Cognitive Preservation Project 2.0

Red light therapy, also called photobiomodulation (PBM) is an emerging, non-invasive treatment that may improve cognitive function and/or motor symptoms associated with neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. This 12 month study aims to examine the effect of twice daily red-light therapy using a red-light helmet on cognition and motor symptoms in people who have been diagnosed with either of these conditions. 

People who meet the following criteria may be eligible to participate: 

• 55+ years old
• Diagnosed with Alzheimer’s disease or Parkinson’s disease
• Fluent in English
• Normal or corrected to normal vision

Participation Details

Participants will be asked to wear a red-light helmet twice daily for 24 minutes each session for 12-months. Participation will involve attending 5 appointments at the National Institute of Integrative Medicine (NIIM) in Hawthorn VIC across the 12-month period to undergo tests of cognitive and/or motor abilities, mood assessment, and tolerability check.